[Effect of the nonspecific prevention of thrombogenic complications on late results in the combined treatment of bladder cancer].
Altogether 106 patients with bladder carcinoma (Stage T3NxMo) after combined treatment were followed-up for 5 yrs. Nicotinic acid and aspirin at common doses were administered to 51 patients (the 1st group) during pre- and post-operative radiation therapy. The other 55 patients (the 2nd group) did not receive these drugs. Relapses were noted in 33.3% of the patients of the 1st group and in 76.3% of the patients of the 2nd group. The 5-year survival in the 1st group was 72.5% and in the 2nd group 27.4%. The administration of nicotinic acid and aspirin to patients during pre- and postoperative gamma-beam therapy was shown to raise the body antitumor resistance.